Malaria Journal

official impact factor 3.49

Open Access Highly Access Research

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial

Issaka Sagara1*, Stephen Rulisa2, Wilfred Mbacham3, Ishag Adam4, Kourane Sissoko1, Hamma Maiga1, Oumar B Traore1, Niawanlou Dara1, Yahia T Dicko1, Alassane Dicko1, Abdoulaye Djimdé1, F Herwig Jansen5 and Ogobara K Doumbo1

Author Affiliations

1 Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Medicine, Pharmacy and Odonto-Stomatology, University of Bamako, Bamako, Mali

2 Kigali Central University Hospital, Kigali Rwanda

3 The Laboratory for Public Health Biotechnology, The Biotechnology Centre, University of Yaounde I, Yaounde, Cameroon

4 University of Khartoum, Khartoum, Sudan

5 Dafra Pharma NV/SA, Slachthuisstraat 30/7, 2300 Turnhout, Belgium

For all author emails, please log on.

Malaria Journal 2009, 8:63 doi:10.1186/1475-2875-8-63

Published: 14 April 2009

Additional files

Additional file 1:

Sulfamethoxypyrazine-Pyrimethamine v.s Sulfadoxine-Pyrimethamine. History and comparison of Sulfamethoxypyrazine-Pyrimethamine_vs_Sulfadoxine-Pyrimethamine

Format: DOC Size: 26KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data